Abstract
Objective Pedicle screw (PS) placement to facilitate stability and spinal fusion following lumbar decompression surgery is associated with significant soft tissue damage and blood loss. The present study evaluated differences in operative time and blood loss between PS fixation and the use of new implantable facet fusion device (FFX®) during surgeries of patients with lumbar spinal stenosis (LSS).
Methods Patients from a single institution who underwent posterior lumbar fusion surgery for LSS with either PS fixation or the FFX device were included in this non-randomized, retrospective study. The PS group consisted of patients with LSS operated on in 2016 and the FFX group included patients operated on in 2018. Both groups excluded patients whose procedures were combined with additional implanted devices. All procedures were performed by the same surgeon. Select patient demographics, number of levels operated on, operative time and estimated operative blood loss were collected retrospectively. Differences between the two groups were assessed using the unpaired Wilcoxon two-sample test.
Results Of the 70 patients undergoing fusion surgery included in the study, there were 28 in the PS arm and 42 in the FFX arm. Mean age for the PS group was 67.5 ± 9.3 years (range 42.7 to 87.5) compared to 70.4 ± 11.5 years (range 49.7 to 86.6) for the FFX group. The PS group had a greater percentage of females (57.1%) compared to the FFX group (31.0%). The mean number of levels operated were similar between the PS and FFX groups (2.3 ± 1.1 vs. 2.2 ± 1.0, respectively). Mean operative time was significantly longer for the PS group versus the FFX group (152.5 ± 39.4 vs. 99.4 ± 44.0 minutes; p<0.001). Mean operative blood loss was also significantly greater for the PS group compared to the FFX group (446.5 ± 272.0 vs. 251.0 ± 315.9 mL; p<0.001). Differences were independent of the number of levels operated on.
Conclusion The use of the FFX device is associated with a significant reduction in both operative time and blood loss compared to PS fixation in LSS patients undergoing spinal fusion surgery.
Competing Interest Statement
Author (RS) reports being a designer in the patents of the FFX technology.
Clinical Trial
Study was a retrospective analysis. Not a clinical trial or interventional study.
Funding Statement
No external funding was received to support this research or for the authorship/publication of this paper.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data available upon request.